By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TrovaGene, Inc. 

420 Lexington Avenue
Suite 170
New York  New York  10170  U.S.A.
Phone: n/a Fax: n/a



Company News
TrovaGene, Inc. Upgraded To Russell 3000, Small Cap And Global Indexes 6/29/2015 7:06:23 AM
Clinical Data Featuring TrovaGene, Inc.'s Urine-Based Liquid Biopsy Platform To Be Presented At Two Upcoming Medical Conferences 6/8/2015 10:05:03 AM
TrovaGene, Inc. Launches Commercial Marketing Campaign At The 2015 ASCO Annual Meeting 5/28/2015 7:50:42 AM
Clinical Utility Of TrovaGene, Inc.'s Urine-Based Liquid Biopsy Platform To Be Highlighted At The ASCO Meeting 5/14/2015 10:57:03 AM
TrovaGene, Inc. Announces First Quarter 2015 Financial Results 5/6/2015 7:56:12 AM
Cost Benefit Analysis Of TrovaGene, Inc.'s Precision Cancer Monitoring Solution To Be Presented At The Association For Value-Based Cancer Care In Washington, DC 5/4/2015 12:26:41 PM
TrovaGene, Inc. Schedules Release Of First Quarter 2015 Financial Results And Investor Conference Call 4/28/2015 10:54:49 AM
TrovaGene, Inc.'s Urine-Based HPV Assay To Be Featured In Presentation At The 13th Annual Cervical Cancer Conference And HPV Consortium In Beijing 4/23/2015 11:25:02 AM
Poster Presentations At 2015 AACR Annual Meeting To Highlight Clinical Utilities And Advantages Of TrovaGene, Inc.'s ctDNA Precision Cancer Monitoring Platform 4/21/2015 2:10:54 PM
TrovaGene, Inc.'s Urinary ctDNA Assay Outperforms Tissue Biopsy In Clinical Study For The Detection Of EGFR T790M Mutations In Metastatic Lung Cancer Patients 4/17/2015 10:33:11 AM